Ship Healthcare (3360) Q4 2026 earnings summary

Executive summary

• Net sales rose 5.9% year-over-year to ¥718.2 billion, exceeding the plan by 2.6%, while operating profit declined 1.2% to ¥24.5 billion and profit attributable to owners of parents fell 11.5% to ¥13.4 billion.

• The group advanced its medium-term plan, focusing on business integration, Medical IT, and logistics expansion, despite industry headwinds from rising costs and workforce shortages.

• Large project deliveries and new SPD facility contracts supported growth, but profit was impacted by higher costs and absence of prior year one-time gains.

Financial highlights

• Gross profit was flat year-over-year at ¥66.7 billion, while operating profit margin declined to 3.4%.

• Ordinary profit increased 1.2% year-over-year to ¥26.3 billion; comprehensive income fell 8.1% to ¥12.9 billion.

• Net income per share was ¥144.19, down from ¥160.34 the previous year.

• Net assets increased to ¥152.4 billion, with an equity capital ratio of 39.2%.

• Cash and cash equivalents at year-end were ¥78.6 billion, up ¥3.7 billion from the prior year.

Outlook and guidance

• FY03/27 net sales are projected at ¥740 billion, up 3.0% year-over-year, with operating profit forecast to rise 6.2% to ¥26 billion and profit attributable to owners of parents expected to increase 19.5% to ¥16 billion.

• Medium-term plan targets 5% sales CAGR, 4% operating profit margin, and 12% ROE by FY2030.

• Dividend per share planned to increase to ¥65.